These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32580898)

  • 21. [ANMCO Position paper: Cardiological outpatient activities in the transition phase of the COVID-19 pandemic].
    Valente S; Colivicchi F; Francese MG; Di Lenarda A; Roncon L; Murrone A; Caldarola P; Bilato C; Amodeo E; Aspromonte N; Cipriani M; Domenicucci S; Imazio M; Scotto di Uccio F; Urbinati S; Gulizia MM; Gabrielli D
    G Ital Cardiol (Rome); 2020 Aug; 21(8):584-588. PubMed ID: 32686782
    [No Abstract]   [Full Text] [Related]  

  • 22. Experience of an acute old age psychiatric ward in the early stages of the coronavirus disease 2019 pandemic in the UK.
    Nizama-Vía A; Alonso-Sánchez A; Serra-Mestres J
    Psychogeriatrics; 2020 Nov; 20(6):920-922. PubMed ID: 32869406
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of vascular risk factor burden on the severity of COVID-19 illness, a retrospective cohort study.
    Du H; Pan X; Liu N; Chen J; Chen X; Werring DJ; Ambler G; Li X; Chen R; Zhang Y; Huang H; Lin F; Xia P; Chen C; Zheng Z; Wu S; Lei H; Gao L; Huang M; Lin K; Xu X; Luo Y; Zhao Z; Li C; Lin H; Lin Y; Huang Z; Cao R; Chen L;
    Respir Res; 2020 Sep; 21(1):241. PubMed ID: 32957997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis.
    Ielapi N; Licastro N; Provenzano M; Andreucci M; Franciscis S; Serra R
    Biomark Med; 2020 Jun; 14(9):713-716. PubMed ID: 32426991
    [No Abstract]   [Full Text] [Related]  

  • 25. Reopening echocardiography services to care for our patients, including the COVID-19 patient population.
    Ignatowski D; Umland M; Khandheria BK
    Eur Heart J Cardiovasc Imaging; 2020 Oct; 21(10):1175. PubMed ID: 32808037
    [No Abstract]   [Full Text] [Related]  

  • 26. Priority plan for invasive cardiac electrophysiology procedures during the coronavirus disease 2019 (COVID-19) pandemic.
    Wang NC; Jain SK; Estes NAM; Barrington WW; Bazaz R; Bhonsale A; Kancharla K; Shalaby AA; Voigt AH; Saba S
    J Cardiovasc Electrophysiol; 2020 Jun; 31(6):1255-1258. PubMed ID: 32323382
    [No Abstract]   [Full Text] [Related]  

  • 27. At the heart of COVID-19.
    Khan IH; Zahra SA; Zaim S; Harky A
    J Card Surg; 2020 Jun; 35(6):1287-1294. PubMed ID: 32369872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis.
    Lippi G; Lavie CJ; Sanchis-Gomar F
    Prog Cardiovasc Dis; 2020; 63(3):390-391. PubMed ID: 32169400
    [No Abstract]   [Full Text] [Related]  

  • 29. SARS-CoV-2-Induced Immune Dysregulation and Myocardial Injury Risk in China: Insights From the ERS-COVID-19 Study.
    Li D; Chen Y; Jia Y; Tong L; Tong J; Wang W; Liu Y; Wan Z; Cao Y; Zeng R
    Circ Res; 2020 Jul; 127(3):397-399. PubMed ID: 32375560
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19: how things change in a short while.
    Stolfo D; Sinagra G
    Eur Heart J Cardiovasc Pharmacother; 2020 Sep; 6(5):280-281. PubMed ID: 32678899
    [No Abstract]   [Full Text] [Related]  

  • 31. Cardiovascular molecular mechanisms of disease with COVID-19.
    Foo R; Wang Y; Zimmermann WH; Backs J; Wang DW
    J Mol Cell Cardiol; 2020 Apr; 141():107. PubMed ID: 32289321
    [No Abstract]   [Full Text] [Related]  

  • 32. Editor's presentation: 'Les liaisones dangerouses. The heart in the time of COVID-19'.
    Piepoli MF
    Eur J Prev Cardiol; 2020 Jul; 27(10):1011-1013. PubMed ID: 32583735
    [No Abstract]   [Full Text] [Related]  

  • 33. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study.
    Du RH; Liang LR; Yang CQ; Wang W; Cao TZ; Li M; Guo GY; Du J; Zheng CL; Zhu Q; Hu M; Li XY; Peng P; Shi HZ
    Eur Respir J; 2020 May; 55(5):. PubMed ID: 32269088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 and obesity.
    Finer N; Garnett SP; Bruun JM
    Clin Obes; 2020 Jun; 10(3):e12365. PubMed ID: 32342637
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognosticating COVID-19: A need for Africa-specific laboratory predictors.
    Omuse G; Maranga J; Abdillah A; Maina D
    S Afr Med J; 2020 May; 110(6):12945. PubMed ID: 32880540
    [No Abstract]   [Full Text] [Related]  

  • 36. The potential sudden shift in clinical research and epidemiology of cardiovascular diseases, caused by COVID-19.
    Pezel T; Lima JAC
    Arch Cardiovasc Dis; 2020; 113(6-7):378-380. PubMed ID: 32586675
    [No Abstract]   [Full Text] [Related]  

  • 37. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
    Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
    Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-6 and severity of COVID-19 patients in Hefei, China.
    Zhao Z; Xie J; Yin M; Yang Y; Ding C; Gao Y; Ma X
    Med Mal Infect; 2020 Oct; 50(7):629-631. PubMed ID: 32593746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neutrophil to lymphocyte ratio as a prognostic marker in COVID-19].
    Basbus L; Lapidus MI; Martingano I; Puga MC; Pollán J
    Medicina (B Aires); 2020; 80 Suppl 3():31-36. PubMed ID: 32658845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac damage in patients with the severe type of coronavirus disease 2019 (COVID-19).
    Li J; Zhang Y; Wang F; Liu B; Li H; Tang G; Chang Z; Liu A; Fu C; Lv Y; Gao J; Li J
    BMC Cardiovasc Disord; 2020 Nov; 20(1):479. PubMed ID: 33167876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.